Leo Gordon retweeted
At the Department of Biochemistry& Molecular Genetics annual holiday event with the greatest Chair of Biochemistry Ali Shilatifard @ShilatifardLab & the incredible @yuefeng_1 who just published a major article @Nature!
@LurieCancer
Predicting risk in Hodgkin lymphoma for research and clinical practice - goo.gl/scholar/ygezrw #ScholarAlerts
Congratulations!!! Great opportunity We will miss you here.
Excited to announce my next chapter: I'm joining @UTSWNews as the inaugural Director of the Center for Cellular Therapies and Cancer Immunology! Looking forward to building innovative #immunotherapy programs and advancing #cancerresearch with the outstanding team at UTSW. #1/3
Leo Gordon retweeted
This is how we holiday party in the Division of Hematology @SylvesterCancer @UMiamiHealth! So grateful to work with such extraordinary people! ♥️😀🩸@DrSDNimer @CraigMoskMD @DrPlatelet @drsangeetmd @JustinWattsMD
Leo Gordon retweeted
I am deeply honored to receive this award surrounded by so many people who work so hard to improve the lives of cancer patients and their families. @LeonidasPlatan1, thank you for your leadership! 💜
From last evening at the State of the Lurie Cancer Center and Awards presentations event. Presenting the Nora Cooney Compassionate Care Award to @jaltmanmd, Director of our leukemia program! She is a great leader @LurieCancer and @NUFeinbergMed
Vice Chair of the B-Cell Lymphomas NCCN Guidelines Maps Critical Changes From 2024 onclive.com/view/vice-chair-… via @onclive
Leo Gordon retweeted
My daughter's first publication as a 1st author. So proud of her. She is only less than 6 months into her residency! A lot more to come from her in the future. Stay tuned! @NUFeinbergMed
@NU_IntMed @NUIM_Chiefs @dmljmd @SusanQuaggin
gh.bmj.com/content/9/12/e016…
Leo Gordon retweeted
It’s been a great run, but really can’t support the management any longer. I’ll be at the other place! 🦋
Comparative efficacy of lisocabtagene maraleucel in the PILOT study versus second-line chemotherapy regimens in the… pubmed.ncbi.nlm.nih.gov/3947…
New important data confirming importance of CAR t therapy in an older population with co-morbidities
Leo Gordon retweeted
Thanks to everyone who contributed to this pivotal trial. Honored to receive this award #ISHL13. Appreciate also the kind introductory words from Dr Advani. @WilmotCancer l
🏆 Super KUDOS to @WilmotCancer @DrJFriedberg in receipt of the Karl Musshoff Prize for best clinical abstract at #ISHL13.
👏 Incredibly well deserved on the heels of the seminal S1826 @NEJM paper as well as the prior mountain of work/dedication in the field of Hodgkin Lymphoma.
Leo Gordon retweeted
Watch experts @MatthewLunning, DO, FACP, of @unmc @elizabeth_budde, MD, PhD of @cityofhope, @ligordon, MD of @LurieCancerCenter @DrFredLocke, MD of @MoffittNews discuss the current treatment landscape for bispecific antibodies and CAR T in R/R #DLBCL
onclive.com/view/disparities…
Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma | Haematologica haematologica.org/article/vi…
Leo Gordon retweeted
Congratulations to Liam Hendriks on being named our 2024 Roberto Clemente Award nominee!
Vote for Liam: bit.ly/3Zj8J5Q
V. Craig Jordan, PhD, DSc, FAACR: In Memoriam (1947–2024) aacrjournals.org/cancerres/a…
When physicians became “providers “. Those terms need to go away.
Leo Gordon retweeted
Listen in as expert oncologists expand on contemporary sequencing with CD20xCD3 bispecific antibodies in R/R diffuse-large B-cell #lymphoma. @lymphomaphilia @elizabeth_budde @ligordon @DrFredLocke #oncology #hematology onclive.com/view/contemporar…





















